Skip to content
ThetaGradeSign inFree Daily Brief
Not financial advice. ThetaGrade is educational and informational only. Nothing here is a recommendation to buy or sell any security, and it is not tailored to anyone. Options involve substantial risk; read the OCC Characteristics and Risks of Standardized Options. Past performance does not guarantee future results. Methodology

GTBP GT Biopharmalimited data

Nasdaq · Health Care · Pharmaceutical Preparations

Fundamentals
not graded

GT Biopharma (GTBP) is in ThetaGrade’s extended coverage. It does not have a House Rating; this is a fundamentals-only summary from SEC filings, compared with Health Care peers. There is not enough usable data to grade its fundamentals (no recent quarterly XBRL data; 1 of 7 factors have data). 14% of the method weight is backed by data.

Data as of .

Growth

no data
Revenue growth (TTM, YoY)data gap
EPS growth (TTM, YoY)data gap

Profitability

no data
Operating margin (TTM)data gap
Free-cash-flow margin (TTM)data gap

Balance sheet

Below average
Net debt / EBITDAdata gap
Current ratioBelow average
Interest coveragedata gap

From the filings

  • Net cash

Next earnings

No reliable estimate: only 1 earnings releases (Item 2.02 8-Ks matched to 10-Q/10-K) found. Check the company’s investor-relations page.

Why no House Rating

  • price under $10
  • market cap under $1B

House Ratings, Weekly Picks and the CSP screen cover the Tier 1 universe only. Methodology

Get rating changes in the free Daily Brief

The market’s key events and signals, digested before the open.

  • ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
  • ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
  • ✓ OPEX, FOMC, CPI and jobs-day reminders

Double opt-in: we email a confirmation link first. No spam, unsubscribe anytime. We never sell your email. Privacy. Educational content, not financial advice.

Free. Want more? See Premium.

Educational summary from public SEC filings; not a House Rating and not financial advice. Sector: SIC 2834 (Pharmaceutical Preparations). Source: SEC EDGAR filings. Data as of 2026-10-21.